Evaluation of the accuracy of a Novel Medtronic Extended Life Continuous Glucose Sensor in people with type 1 diabetes

St Vincent's Hospital Melbourne0 个研究点目标入组 40 人开始时间: 2020年11月5日最近更新: 2020年11月16日

适应症

试验速览

暂无简介。

•Participants will be considered for inclusion in the study if they meet all the following criteria:
•1. Participant is over 18 years of age at time of screening.
•2. A clinical diagnosis of Type-1 Diabetes, as determined by the Investigator.
•3. Participant is using insulin to treat his/her Diabetes.
•4. Currently using a sensor or has experience with sensor use.
•5. Preference will be given to subjects who have a history of hypoglycaemia.
•6.Participant is willing to comply with all requirements associated with the protocol.

•Participants will be excluded from the study for any of the following reasons:
•1. Participant has a positive pregnancy screening test.
•2. Any known allergies to glucocorticoid steroids
•3. Participant is female and plans to become pregnant during the study.
•4. Participant is unable to tolerate tape adhesive in the region of sensor placement.
•5. Participant has any unresolved adverse skin condition in the region of sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection).
•6. Recent (< 3months) episode of severe hypoglycaemia or Diabetic ketoacidosis.
•7. Known major life-threatening disease or psychiatric illness.

发起方

St Vincent's Hospital Melbourne